Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
74.30
2.92 (4.09%)
At close: Jun 23, 2025, 3:59 PM
74.28
-0.03%
Pre-market: Jun 24, 2025, 07:00 AM EDT
4.09% (1D)
| Bid | 73.3 |
| Market Cap | 7.88B |
| Revenue (ttm) | 685.45M |
| Net Income (ttm) | 132.85M |
| EPS (ttm) | 1.15 |
| PE Ratio (ttm) | 64.61 |
| Forward PE | 26.89 |
| Analyst | Strong Buy |
| Ask | 75.1 |
| Volume | 715,415 |
| Avg. Volume (20D) | 1,697,566 |
| Open | 71.38 |
| Previous Close | 71.38 |
| Day's Range | 71.00 - 74.40 |
| 52-Week Range | 29.42 - 117.33 |
| Beta | 0.18 |
About CORT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CORT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CORT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Corcept Therapeutics is scheduled to release its earnings on Jul 28, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-7.58%
Corcept Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
1 month ago
-4.33%
Corcept Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results. Also, HC Wainwright maintained a Buy rating on the stock but lowered its price target from $150 to $145.
1 month ago · seekingalpha.com
Corcept Therapeutics Incorporated (CORT) Q1 2025 Earnings Call TranscriptCorcept Therapeutics Incorporated (NASDAQ:CORT ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Atabak Mokari - Chief Financial Officer Sean Maduck - President, Endocrino...
